Cognetivity Neurosciences Ltd logo

Cognetivity Neurosciences Ltd

OTCPK:CGNSF (Canada)  
$ 0.01 0 (0%) 09:30 AM EST
At Loss
Market Cap:
$ 779.00K
Enterprise V:
$ 1.78M
Volume:
-
Avg Vol (2M):
65.22K
Trade In:
Volume:
-
At Loss
Avg Vol (2M):
65.22K
PE Ratio PS Ratio PB Ratio Price-to-FCF Market Cap
Current and historical daily PE Ratio for Cognetivity Neurosciences Ltd ( ) from 2018 to Sep 25 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. Cognetivity Neurosciences stock (CGNSF) PE ratio as of Sep 25 2024 is 0. More Details

Cognetivity Neurosciences Ltd (CGNSF) PE Ratio (TTM) Chart

To

Cognetivity Neurosciences Ltd (CGNSF) PE Ratio (TTM) Historical Data

Total 1234
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 14
Cognetivity Neurosciences PE Ratio (TTM) Historical Data
Date PE Ratio (TTM) Data Date PE Ratio (TTM) Data
2024-09-25 At Loss 2024-07-23 At Loss
2024-09-24 At Loss 2024-07-22 At Loss
2024-09-23 At Loss 2024-07-19 At Loss
2024-09-20 At Loss 2024-07-18 At Loss
2024-09-19 At Loss 2024-07-17 At Loss
2024-09-18 At Loss 2024-07-16 At Loss
2024-09-17 At Loss 2024-07-15 At Loss
2024-09-16 At Loss 2024-07-12 At Loss
2024-09-13 At Loss 2024-07-11 At Loss
2024-09-12 At Loss 2024-07-10 At Loss
2024-09-11 At Loss 2024-07-09 At Loss
2024-09-10 At Loss 2024-07-08 At Loss
2024-09-09 At Loss 2024-07-05 At Loss
2024-09-06 At Loss 2024-07-02 At Loss
2024-09-05 At Loss 2024-07-01 At Loss
2024-09-04 At Loss 2024-06-28 At Loss
2024-09-03 At Loss 2024-06-27 At Loss
2024-08-30 At Loss 2024-06-26 At Loss
2024-08-29 At Loss 2024-06-25 At Loss
2024-08-28 At Loss 2024-06-24 At Loss
2024-08-27 At Loss 2024-06-21 At Loss
2024-08-26 At Loss 2024-06-20 At Loss
2024-08-23 At Loss 2024-06-18 At Loss
2024-08-22 At Loss 2024-06-17 At Loss
2024-08-21 At Loss 2024-06-14 At Loss
2024-08-20 At Loss 2024-06-13 At Loss
2024-08-19 At Loss 2024-06-12 At Loss
2024-08-16 At Loss 2024-06-11 At Loss
2024-08-15 At Loss 2024-06-10 At Loss
2024-08-14 At Loss 2024-06-07 At Loss
2024-08-13 At Loss 2024-06-06 At Loss
2024-08-12 At Loss 2024-06-05 At Loss
2024-08-09 At Loss 2024-06-04 At Loss
2024-08-08 At Loss 2024-06-03 At Loss
2024-08-07 At Loss 2024-05-31 At Loss
2024-08-06 At Loss 2024-05-30 At Loss
2024-08-05 At Loss 2024-05-29 At Loss
2024-08-02 At Loss 2024-05-28 At Loss
2024-08-01 At Loss 2024-05-24 At Loss
2024-07-31 At Loss 2024-05-23 At Loss
2024-07-30 At Loss 2024-05-22 At Loss
2024-07-29 At Loss 2024-05-21 At Loss
2024-07-26 At Loss 2024-05-20 At Loss
2024-07-25 At Loss 2024-05-17 At Loss
2024-07-24 At Loss 2024-05-16 At Loss

Cognetivity Neurosciences Ltd (CGNSF) PE Ratio (TTM) Comparison

Company Market Cap(Mil) PE Ratio (TTM)

Business Description

Business Description

Description
Cognetivity Neurosciences Ltd is a technology company developing a cognitive testing platform, the Integrated Cognitive Assessment (ICA), for use in medical, commercial, and consumer environments for potentially allowing early diagnosis of dementia. The Company is considered operating in one segment for development of the ICA platform. Its geographical areas include Canada, United Kingdom and Dubai.